We are live on ! Find out more
Loomis, Sayles & Company

Loomis, Sayles & Company Portfolio holdings

AUM $74.3B
1-Year Est. Return 24.01%
This Fund
S&P 500
This Quarter Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
Cap. Flow
-$2.3B
Cap. Flow %
-2.9%
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91

Sector Composition

Rank Sector Weight
1 Technology 27.48%
2 Consumer Discretionary 18.83%
3 Communication Services 18.1%
4 Healthcare 11.79%
5 Financials 9.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MOD icon
126
Modine Manufacturing
MOD
$10.4B
$46.4M 0.06%
400,062
-11,690
-3% -$1.5M
KNSL icon
127
Kinsale Capital Group
KNSL
$8.51B
$46.1M 0.06%
99,088
-10,987
-10% -$5.2M
PCOR icon
128
Procore
PCOR
$8.67B
$46.1M 0.06%
614,660
+191,546
+45% +$13.6M
LOPE icon
129
Grand Canyon Education
LOPE
$3.98B
$45.5M 0.06%
277,990
-8,124
-3% -$1.24M
BWIN
130
Baldwin Insurance Group
BWIN
$2.86B
$44.2M 0.06%
1,141,544
-136,633
-11% -$6.37M
MSCI icon
131
MSCI
MSCI
$40.9B
$44.1M 0.06%
73,506
-4,295
-6% -$2.58M
TLN
132
Talen Energy Corp
TLN
$16.7B
$43.5M 0.06%
216,116
+2,972
+1% +$580K
ROIV icon
133
Roivant Sciences
ROIV
$26.2B
$43.4M 0.05%
3,671,011
-241,194
-6% -$2.85M
EVTC icon
134
Evertec
EVTC
$1.78B
$43M 0.05%
1,246,057
-36,405
-3% -$1.25M
NOVT icon
135
Novanta
NOVT
$6.29B
$43M 0.05%
281,255
-8,218
-3% -$1.39M
COLM icon
136
Columbia Sportswear
COLM
$2.94B
$42.9M 0.05%
511,281
-15,245
-3% -$1.28M
LGND icon
137
Ligand Pharmaceuticals
LGND
$6.36B
$42.6M 0.05%
397,700
+24,921
+7% +$2.82M
PATK icon
138
Patrick Industries
PATK
$2.85B
$42M 0.05%
505,506
-14,775
-3% -$1.32M
WRBY icon
139
Warby Parker
WRBY
$3.27B
$41.9M 0.05%
1,732,023
-50,606
-3% -$1.03M
NTRA icon
140
Natera
NTRA
$46.4B
$41M 0.05%
259,146
-7,941
-3% -$1.16M
IPAR icon
141
Interparfums
IPAR
$3.94B
$40.7M 0.05%
309,111
-9,031
-3% -$1.16M
PARA
142
DELISTED
Paramount Global Class B
PARA
$40.3M 0.05%
3,854,751
-109,465
-3% -$1.18M
AD
143
Array Digital Infrastructure
AD
$3.05B
$39.5M 0.05%
629,195
-4,877
-0.8% -$298K
HURN icon
144
Huron Consulting
HURN
$2.42B
$39.3M 0.05%
316,522
-9,247
-3% -$1.08M
WIX icon
145
WIX.com
WIX
$2.52B
$39.3M 0.05%
183,068
-5,678
-3% -$1.09M
RGA icon
146
Reinsurance Group of America
RGA
$16.1B
$39.1M 0.05%
182,847
-26,836
-13% -$5.85M
VNT icon
147
Vontier
VNT
$4.74B
$38.9M 0.05%
1,067,146
-1,706
-0.2% -$63K
BECN
148
DELISTED
Beacon Roofing Supply, Inc.
BECN
$38.5M 0.05%
379,145
+35,512
+10% +$3.58M
KRNT icon
149
Kornit Digital
KRNT
$791M
$38.3M 0.05%
1,237,453
+893,463
+260% +$25.6M
DORM icon
150
Dorman Products
DORM
$4.18B
$38.1M 0.05%
294,355
-8,599
-3% -$1.1M

Similar funds

Loomis, Sayles & Company's Q4 2024 Portfolio in Review

As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
  • Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
  • Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
  • Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
  • Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
  • Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
  • Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.

Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.